Loading clinical trials...
Loading clinical trials...
To evaluate the safety, tolerability, efficacy, and pharmacokinetics of MDX-1106 when administered to patients with advanced non-small cell lung cancer, colorectal cancer, malignant melanoma, clear ce...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Bristol-Myers Squibb
NCT07446322 · Ras-mutated Metastatic Colorectal Cancer, mCRC, and more
NCT02600949 · Metastatic Colorectal Adenocarcinoma, Metastatic Pancreatic Ductal Adenocarcinoma, and more
NCT05919264 · Cancer, Colorectal Cancer, and more
NCT06855771 · Carcinoma, Non-Small-Cell Lung
NCT07541924 · Colorectal Cancer Screening, Colonic Polyps/Colonoscopy/Colorectal Neoplasms, and more
Johns Hopkins Unv., School of Medicine
Baltimore, Maryland
Henry Ford Health System
Detroit, Michigan
Washington University School of Medicine - Barnes Jewish Hospital
St Louis, Missouri
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions